Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Recharacterization of EmAGA, a Potential Candidate for Novel ALL Therapeutics.

Biomolecules - 7 May 2026

Lin Qiange, Zhang Yuxin, Lin Junyou, Ye Yilin, Qian Xin, Lu Xinrong, Lyu Shaoxian, Geng Xinliu, Chen Li, Sun Guiqin

Abstract excerpt

Aspartylglucosaminidase (AGA) is an amidohydrolase that can hydrolyze the amide bond between N-acetylglucosamine (GlcNAc) and asparagine (Asn), producing N-acetylglucosamine and aspartic acid (Asp). AGA is distributed in both eukaryotes and prokaryotes. In this study, we identified the sequence of AGA in Elizabethkingia meningoseptica (EmAGA), cloned and expressed it in Escherichia coli, and recharacterized its...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Flavobacteriaceae
Share to Hydrolysis
Share to Molecular Dynamics Simulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Precursor Cell Lymphoblastic Leukemia-Lymphoma

Share to Protein Conformation

Share to Sequence Homology

Share to Substrate Specificity

Share to Whole Genome Sequencing

Source

Open in PubMed Open full text

Identifiers

PMID: 42194039
DOI: 10.3390/biom16050690
PMCID: PMC13204146

Genes

AGA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Recharacterization of EmAGA, a Potential Candidate for Novel ALL Therapeutics.PMID 42194039Read ↗

Structural and functional diversity of asparaginases: Overview and recommendations for a revised nomenclatureSemantic proximity Read ↗

Mutations in asparaginase II from E. coli and implications for inactivation and PEGylation.Semantic proximity Read ↗

Metagenomic discovery and functional validation of L-asparaginases with anti-leukemic effect from the Caspian SeaSemantic proximity Read ↗

Possible mechanism of metabolic and drug resistance with L-asparaginase therapy in childhood leukaemiaSemantic proximity Read ↗

Fluorescence-Activated Cell Sorting of Human l-asparaginase Mutant Libraries for Detecting Enzyme Variants with Enhanced Activity.Semantic proximity Read ↗

Structural and functional role of Gly281 in L-asparaginase from Erwinia carotovora.Semantic proximity Read ↗

Structure, Substrate Complexation and Reaction Mechanism of Bacterial AsparaginasesSemantic proximity Read ↗

<i>In Silico</i> -Driven Engineering of <i>Halomonas elongata</i> L-Asparaginase: Towards Enhanced Proteolytic Resistance in Lymphoblastic LeukemiaSemantic proximity Read ↗

Structural and biophysical studies of new L-asparaginase variants: lessons from random mutagenesis of the prototypic Escherichia coli Ntn-amidohydrolase.Semantic proximity Read ↗

Structural and biochemical properties of L‐asparaginaseSemantic proximity Read ↗

Crystal structure of a mutant glycosylasparaginase shedding light on aspartylglycosaminuria-causing mechanism as well as on hydrolysis of non-chitobiose substrate.Semantic proximity Read ↗

Metagenomic discovery and functional validation of L-asparaginases with anti-leukemic effect from the Caspian SeaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.